Representative before the EPO

Employment test 51 - 200 employees
Company dna reddie and grose llp
operating since 1907
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Jonathan Mark Davies has worked on the following 2 EPO patent applications which have been published in the last five years:

EP10785169

COMBINATION OF DROLOXIFENE AND CLOPIDOGREL

IPC classification:
A61K 31/138, A61K 31/4365, A61P 9/00, A61P 9/10, A61P 19/02, A61P 25/28, A61P 29/00, A61P 37/00, A61P 37/06, C07D 495/04
Agent:
Jonathan Mark Davies, Reddie & Grose LLP
Status:
APPLICATION WITHDRAWN
EP13701416

NOVEL 2-AMINO-4,5,6,8-TETRAHYDROPYRAZOLO[3,4-b]THIAZOLO [4,5-d]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS

IPC classification:
A61K 31/5517, A61P 25/28, C07D 513/04
Agent:
Multiple attorneys, Reddie & Grose LLP
Status:
PATENT GRANTED

Please Sign in to use this feature